identifi
adult
age
year
age
allogen
syngen
autolog
hsct
recipi
test
posit
hrv
new
hospitalweil
cornel
medic
colleg
new
york
citi
march
april
patient
test
posit
hrv
condit
also
includ
clinic
laboratori
radiograph
data
abstract
exist
electron
medic
record
avail
lung
tissu
specimen
patient
underw
biopsi
episod
proven
hrv
pneumonia
review
one
cm
studi
approv
institut
review
board
weill
cornel
medic
colleg
institut
hsct
recipi
uri
lrti
symptom
routin
screen
cultur
andor
molecular
method
viral
infect
via
nasopharyng
np
swab
bronchoscopi
bal
begin
march
laboratori
implement
refer
molecular
test
respiratori
virus
xtag
respiratori
viral
panel
rvp
luminex
molecular
diagnost
toronto
canada
conduct
viracor
laboratori
lee
summit
missouri
usa
rvp
assay
compris
multiplex
polymeras
chain
reaction
pcr
follow
multiplex
primer
extens
step
rvp
assay
detect
respiratori
virus
human
metapneumoviru
influenza
influenza
b
parainfluenza
virus
piv
respiratori
syncyti
virus
rsv
b
adenoviru
hrv
addit
subtyp
influenza
subtyp
addit
rvp
assay
bal
specimen
hsct
recipi
suspect
pneumonia
evalu
follow
microbiolog
studi
bacteri
gram
stain
cultur
fungal
calcofluor
potassium
hydroxid
stain
cultur
bacillu
stain
cultur
legionella
cultur
pneumocysti
jirovecii
direct
test
respiratori
viru
cultur
includ
cytomegaloviru
influenza
piv
rsv
adenoviru
uri
defin
clinic
symptom
includ
rhinorrhea
nasal
congest
pharyng
cough
without
clinic
radiograph
evid
lower
respiratori
involv
hypoxia
pneumonia
defin
new
radiograph
pulmonari
infiltr
patient
sign
symptom
lrti
includ
cough
dyspnea
sputum
product
fever
separ
subsequ
pneumonia
episod
requir
least
period
episod
pneumonia
classifi
proven
hrv
pneumonia
hrv
isol
bal
fluid
ii
possibl
hrv
pneumonia
hrv
isol
np
swab
bronchoscopi
perform
iii
pneumonia
hrv
detect
np
swab
bal
fluid
episod
pneumonia
neutropenia
defin
absolut
neutrophil
count
lymphopenia
defin
absolut
lymphocyt
count
occur
within
week
hrv
infect
hypoalbuminemia
defin
serum
albumin
mgdl
invas
fungal
infect
defin
accord
european
organ
research
treatment
cancermycos
studi
group
definit
descript
statist
express
median
valu
rang
interquartil
rang
iqr
evalu
factor
associ
proven
possibl
hrv
pneumonia
first
detect
hrv
post
transplant
univari
analysi
use
fisher
exact
test
appropri
categor
variabl
continu
variabl
consid
signific
variabl
univari
analysi
subsequ
analyz
multivari
logist
regress
data
analyz
use
stata
colleg
station
texa
usa
patient
follow
year
first
hrv
infect
march
april
patient
underw
hsct
autolog
allogen
syngen
patient
hrv
infect
median
day
iqr
post
transplant
addit
patient
transplant
march
also
hrv
infect
studi
period
therefor
total
hsct
recipi
includ
patient
receiv
allogen
hsct
patient
receiv
autolog
hsct
patient
receiv
syngen
hsct
condit
regimen
myeloabl
patient
addit
patient
demograph
transplant
characterist
comorbid
present
tabl
hrv
infect
includ
uri
proven
possibl
hrv
pneumonia
occur
peak
infect
rate
observ
octob
march
april
fig
median
age
initi
detect
hrv
post
hsct
year
rang
seventeen
patient
inpati
admit
hsct
inpati
admit
acut
reason
outpati
patient
met
clinic
criteria
uri
pneumonia
respect
none
patient
histori
pneumonia
within
day
prior
hrv
infect
eleven
patient
concurr
bacteremia
accord
definit
episod
hrv
pneumonia
proven
hrv
pneumonia
n
possibl
hrv
pneumonia
n
nine
patient
proven
hrv
pneumonia
patient
possibl
hrv
pneumonia
respiratori
bacteri
fungal
viral
pathogen
univari
analysi
follow
variabl
associ
proven
possibl
hrv
pneumonia
first
hrv
detect
neutropenia
odd
ratio
confid
interv
ci
p
hypoalbuminemia
ci
p
receipt
h
antibiot
therapi
within
previou
day
ci
p
isol
respiratori
ci
p
multivari
analys
hypoalbuminemia
ci
p
isol
respiratori
ci
p
remain
independ
associ
proven
possibl
hrv
pneumonia
first
detect
hrv
post
transplant
tabl
transplant
type
intens
condit
regimen
associ
proven
possibl
hrv
pneumonia
figur
outlin
episod
pneumonia
hrv
associ
period
follow
initi
detect
hrv
post
hsct
among
patient
present
hrv
uri
first
hrv
detect
subsequ
episod
proven
possibl
hrv
pneumonia
subsequ
episod
pneumonia
hrv
detect
test
median
time
hrv
uri
first
episod
pneumonia
day
rang
patient
proven
possibl
hrv
pneumonia
day
rang
patient
pneumonia
hrv
detect
test
among
patient
present
proven
possibl
hrv
pneumonia
first
hrv
detect
subsequ
episod
proven
possibl
hrv
pneumonia
subsequ
episod
pneumonia
hrv
detect
test
median
time
second
episod
pneumonia
day
rang
among
patient
proven
possibl
hrv
pneumonia
day
day
among
patient
pneumonia
hrv
detect
test
total
episod
proven
hrv
pneumonia
episod
possibl
hrv
pneumonia
occur
among
hsct
recipi
studi
period
tabl
one
addit
respiratori
detect
pneumonia
episod
bacteri
n
fungal
n
viral
n
studi
period
patient
episod
pneumonia
hrv
detect
bal
fluid
among
patient
proven
hrv
pneumonia
allogen
hsct
recipi
diseas
gvhd
receiv
antibiot
within
previou
day
fever
cough
sputum
product
dyspnea
common
symptom
proven
hrv
pneumonia
episod
upper
respiratori
tract
sampl
analyz
within
previou
week
hrv
detect
specimen
anoth
respiratori
pathogen
identifi
bal
three
addit
patient
met
criteria
proven
probabl
possibl
fungal
pneumonia
although
number
small
compar
patient
hrv
alon
detect
bal
fluid
patient
bacteri
fungal
viral
respiratori
significantli
differ
term
age
hsct
transplant
type
condit
regimen
gvhd
receipt
antibiot
within
previou
day
data
shown
comput
tomographi
imag
radiolog
report
patient
hrv
monoinfect
bal
fluid
review
studi
investig
sej
tjw
patient
pulmonari
infiltr
bilater
involv
lung
segment
common
infiltr
appear
patchi
ground
glass
opac
n
case
case
opac
becam
confluent
form
consolid
lesion
fig
small
nodular
consolid
surround
ground
glass
predomin
appear
hrv
pneumonia
addit
case
case
infiltr
aggreg
peribronchiolar
distribut
final
patient
present
home
emerg
depart
acut
respiratori
distress
week
fever
upper
respiratori
symptom
dens
bilater
multilobar
consolid
among
patient
oxygen
satur
rang
room
air
patient
oxygen
satur
patient
requir
mechan
ventil
studi
period
tissu
specimen
obtain
via
transbronchi
biopsi
episod
proven
hrv
pneumonia
avail
review
fig
bacteri
present
cultur
bal
fluid
case
escherichia
coli
staphylococcu
aureu
fungal
present
case
pneumocysti
pneumonia
viral
present
case
rsva
fifth
case
evid
bacteri
fungal
viral
case
hrv
bacteri
show
acut
necrot
bronchiti
interstiti
pneumon
cytopath
chang
includ
effac
nuclear
chromatin
preserv
nuclear
membran
ciliocytophthoria
primarili
observ
bronchial
epithelium
case
hrv
pneumocysti
show
type
ii
pneumocyt
hyperplasia
cellular
atypia
interstiti
pneumon
multipl
aggreg
characterist
pneumocysti
organ
also
seen
alveolar
space
case
hrv
rsva
demonstr
subacut
interstiti
pneumon
type
ii
pneumocyt
hyperplasia
unassoci
signific
inflammatori
host
respons
fifth
case
hrv
alon
isol
bal
fluid
histopatholog
featur
includ
slightli
promin
pneumocyt
interstiti
fibrin
deposit
suggest
capillari
injuri
cytoplasm
inclus
multinucl
megaloblast
chang
present
specimen
overal
mortal
total
cohort
patient
year
follow
first
hrv
infect
among
patient
present
proven
hrv
pneumonia
n
possibl
hrv
pneumonia
n
hrv
uri
n
first
hrv
detect
mortal
respect
among
patient
whose
first
pneumonia
hrv
test
pneumonia
n
mortal
respect
pneumonia
immedi
caus
death
patient
microbiolog
data
patient
follow
hrv
stenotrophomona
maltophilia
acinetobact
baumannii
detect
bal
fluid
n
hrv
detect
np
swab
bloodstream
infect
baumannii
bronchoscopi
perform
n
hrv
detect
np
swab
enterococcu
faecium
detect
bal
fluid
bal
fluid
sent
rvp
test
n
studi
period
allogen
hsct
recipi
symptomat
hrv
infect
condit
one
patient
progress
proven
hrv
pneumonia
day
hsct
symptom
resolv
within
week
ultim
die
month
post
hsct
relaps
acut
myelogen
leukemia
one
patient
persist
uri
symptom
hrv
posit
month
post
hsct
aliv
year
first
hrv
infect
third
patient
resolv
uri
symptom
episod
uri
pneumonia
next
year
sinc
molecular
method
respiratori
viru
test
implement
institut
total
hsct
recipi
least
acut
respiratori
ill
includ
episod
proven
possibl
hrv
pneumonia
hrv
infect
rate
peak
fall
earli
spring
consist
season
epidemiolog
observ
studi
temper
climat
furthermor
patient
undergo
hsct
march
april
diagnos
hrv
infect
inpati
transplant
admiss
nearli
half
patient
pneumonia
knowledg
largest
describ
cohort
hsct
recipi
lrti
suspect
use
multiplex
pcr
assay
diagnosi
respiratori
viral
infect
becom
widespread
hrv
increasingli
recogn
signific
caus
pneumonia
immunocompromis
host
univari
analysi
found
marker
increas
immunosuppress
ill
sever
includ
neutropenia
hypoalbuminemia
receipt
antibiot
infect
respiratori
associ
pneumonia
first
detect
hrv
notabl
multivari
analys
presenc
addit
respiratori
pathogen
remain
independ
associ
pneumonia
furthermor
among
episod
proven
hrv
pneumonia
demonstr
bacteri
fungal
viral
find
consist
previou
report
hsct
recipi
pneumonia
hrv
detect
bal
fluid
also
identifi
bacteri
fungal
major
case
among
immunocompet
adult
children
hrv
detect
episod
pneumonia
use
pcr
often
concomit
bacteri
infect
sever
potenti
mechan
hrv
increas
suscept
bacteri
infect
demonstr
vitro
exampl
hrv
stimul
streptococcu
pneumonia
adhes
human
tracheal
epitheli
cell
via
increas
promot
aureu
intern
permiss
cultur
pneumocyt
disrupt
epitheli
cell
barrier
function
dissoci
tight
junction
complex
therebi
facilit
transmigr
bacteria
therefor
hrv
may
similar
influenza
predispos
bacteri
superinfect
mechan
influenza
increas
suscept
bacteri
infect
includ
airway
epitheli
damag
surfac
receptor
chang
alter
neutrophil
function
warrant
studi
model
hrv
infect
viral
uncommon
studi
occur
episod
proven
possibl
hrv
pneumonia
influenza
n
n
rsva
n
notabl
patient
test
panel
respiratori
virus
use
multiplex
pcr
hrv
infect
therefor
likelihood
miss
case
viral
low
find
consist
greer
et
al
show
statist
signific
reduct
viral
compar
respiratori
virus
perhap
mediat
gene
thu
induc
protect
antivir
state
studi
also
identifi
case
pneumonia
hrv
sole
pathogen
identifi
bal
fluid
date
littl
research
perform
pathogenesi
hrv
pneumonia
howev
studi
focus
mechan
exacerb
chronic
lung
diseas
includ
asthma
chronic
obstruct
pulmonari
diseas
copd
may
provid
insight
pathophysiolog
hrv
pneumonia
exampl
patient
asthma
impair
innat
adapt
immun
respons
includ
defici
interferon
product
augment
th
impair
immun
implic
increas
bronchial
inflamm
hyperreact
similar
mechan
identifi
patient
asthma
copd
hrv
may
potenti
caus
parenchym
destruct
direct
cell
injuri
well
alter
immun
respons
immunocompromis
host
although
limit
number
patient
lung
tissu
obtain
episod
proven
hrv
pneumonia
predomin
histopatholog
find
associ
viral
rather
bacteri
fungal
infect
hrv
infect
appear
histolog
compon
necrot
bronchiti
interstiti
process
find
includ
strike
necrot
bronchiti
includ
ciliocytophthoria
bronchial
epitheli
cell
effac
nuclear
chromatin
amidst
bronchial
epitheli
cell
although
without
unequivoc
intranuclear
andor
cytoplasm
inclus
similar
nuclear
chang
seen
within
alveolar
pneumocyt
report
case
hrv
lrti
human
histolog
hrv
capabl
caus
interstiti
alveolar
process
report
patholog
find
includ
bronchiol
obliteran
organ
pneumonia
interstiti
pneumon
acut
chronic
inflamm
fibrinopurul
alveolar
debri
hyperplasia
desquam
alveolar
cell
find
collect
contribut
understand
pathogenesi
pulmonari
hrv
infect
studi
sever
limit
first
data
observ
reli
clinic
specimen
patient
acut
respiratori
ill
may
miss
test
hrv
miss
case
acut
respiratori
ill
would
like
occur
mild
uri
pneumonia
hsct
recipi
pneumonia
hospit
undergo
thorough
microbiolog
evalu
therefor
infer
rel
frequenc
hrv
caus
pneumonia
compar
uri
hsct
popul
concern
may
rais
hrv
detect
lower
airway
reflect
colon
rather
infect
howev
argument
could
made
respiratori
virus
influenza
rsv
known
caus
uri
lrti
sever
studi
demonstr
hrv
replic
primari
human
airway
epitheli
cell
moreov
abil
hrv
replic
bronchial
epithelium
experiment
upper
airway
infect
healthi
human
volunt
demonstr
use
situ
hybrid
anoth
limit
molecular
test
routin
perform
certain
viral
coronaviru
human
bocaviru
atyp
pathogen
chlamydophila
pneumonia
mycoplasma
pneumonia
studi
period
potenti
miss
addit
case
hrv
note
owe
sequenc
homolog
human
enteroviru
hev
hrv
rvp
molecular
method
may
reliabl
distinguish
hev
hrv
howev
test
clinic
perform
characterist
rvp
assay
found
specimen
test
posit
hevhrv
confirm
hrv
person
commun
manufactur
specimen
identifi
hrv
patient
also
high
probabl
hrv
conclus
also
consist
recent
studi
clinic
specimen
n
posit
hrvhev
rvp
subsequ
confirm
posit
hrv
neg
hev
upon
molecular
test
may
risk
factor
hrv
pneumonia
unabl
ascertain
studi
molecular
method
show
signific
genotyp
variat
hrv
identifi
novel
hrv
speci
name
hospit
patient
may
associ
wheez
pneumonia
viremia
often
howev
rate
lrti
vari
consider
among
hrv
speci
owe
differ
patient
popul
primari
outcom
geograph
studi
locat
addit
hrv
viral
load
may
correl
symptom
sever
hospit
immunocompet
pediatr
adult
patient
asthmat
lung
transplant
recipi
unavail
specimen
limit
test
methodolog
unabl
determin
hrv
strain
quantifi
viral
load
current
studi
evalu
whether
factor
may
identifi
patient
risk
sever
recurr
infect
conclus
studi
provid
definit
evid
hrv
signific
lower
respiratori
tract
pathogen
hsct
recipi
given
high
morbid
mortal
associ
pneumonia
hsct
recipi
better
understand
molecular
epidemiolog
distinguish
clinic
featur
hrv
need
patient
underli
hematolog
malign
knowledg
certain
strain
speci
hrv
associ
sever
respiratori
infect
patient
hematolog
malign
may
aid
risk
stratif
patient
hrv
uri
transplant
improv
infect
control
practic
hospit
patient
studi
molecular
epidemiolog
hrv
infect
patient
hematolog
malign
hsct
recipi
ongo
institut
